carbamazepine

Generic: carbamazepine

Labeler: bryant ranch prepack
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name carbamazepine
Generic Name carbamazepine
Labeler bryant ranch prepack
Dosage Form TABLET, CHEWABLE
Routes
ORAL
Active Ingredients

carbamazepine 100 mg/1

Manufacturer
Bryant Ranch Prepack

Identifiers & Regulatory

Product NDC 72162-2572
Product ID 72162-2572_8a43e3ab-fb86-481d-87fe-9506a0d7f970
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075712
Listing Expiration 2026-12-31
Marketing Start 2009-08-26

Pharmacologic Class

Established (EPC)
mood stabilizer [epc]
Mechanism of Action
cytochrome p450 3a4 inducers [moa] cytochrome p450 1a2 inducers [moa] cytochrome p450 2b6 inducers [moa] cytochrome p450 2c9 inducers [moa] cytochrome p450 2c19 inducers [moa]
Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 721622572
Hyphenated Format 72162-2572

Supplemental Identifiers

RxCUI
308973
UNII
33CM23913M
NUI
N0000008486 N0000175751 N0000185506 N0000191266 N0000187064 N0000185507 N0000185607

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name carbamazepine (source: ndc)
Generic Name carbamazepine (source: ndc)
Application Number ANDA075712 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 100 mg/1
source: ndc
Packaging
  • 100 TABLET, CHEWABLE in 1 BOTTLE (72162-2572-1)
  • 500 TABLET, CHEWABLE in 1 BOTTLE (72162-2572-5)
source: ndc

Packages (2)

72162-2572-1 100 TABLET, CHEWABLE in 1 BOTTLE (72162-2572-1) 72162-2572-5 500 TABLET, CHEWABLE in 1 BOTTLE (72162-2572-5)

Ingredients (1)

carbamazepine (100 mg/1)

Linked Drug Pages (1)

CARBAMAZEPINE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "8a43e3ab-fb86-481d-87fe-9506a0d7f970", "openfda": {"nui": ["N0000008486", "N0000175751", "N0000185506", "N0000191266", "N0000187064", "N0000185507", "N0000185607"], "unii": ["33CM23913M"], "rxcui": ["308973"], "spl_set_id": ["c72a0668-7cd7-46a8-86d1-d3c17c4b900f"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Mood Stabilizer [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, CHEWABLE in 1 BOTTLE (72162-2572-1)", "package_ndc": "72162-2572-1", "marketing_start_date": "20251117"}, {"sample": false, "description": "500 TABLET, CHEWABLE in 1 BOTTLE (72162-2572-5)", "package_ndc": "72162-2572-5", "marketing_start_date": "20251117"}], "brand_name": "CARBAMAZEPINE", "product_id": "72162-2572_8a43e3ab-fb86-481d-87fe-9506a0d7f970", "dosage_form": "TABLET, CHEWABLE", "pharm_class": ["Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "72162-2572", "generic_name": "CARBAMAZEPINE", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CARBAMAZEPINE", "active_ingredients": [{"name": "CARBAMAZEPINE", "strength": "100 mg/1"}], "application_number": "ANDA075712", "marketing_category": "ANDA", "marketing_start_date": "20090826", "listing_expiration_date": "20261231"}